- Patent Title: Thiophene derivatives for the treatment of disorders caused by IgE
-
Application No.: US16973701Application Date: 2019-06-20
-
Publication No.: US12018021B2Publication Date: 2024-06-25
- Inventor: Pfrafulkumar Tulshibhai Chovatia , Rickki Lee Connelly , Richard Jeremy Franklin , Gregory William Haslett , Alistair James Henry , James Madden , Judi Charlotte Neuss , Timothy John Norman , Oliver Philps , William Ross Pitt , Konstantinos Rampalakos , Matthew Duncan Selby , Selvaratnam Suganthan , Giancarlo Trani , Zhaoning Zhu
- Applicant: UCB Biopharma SRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SRL
- Current Assignee: UCB BIOPHARMA SRL
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: EP 179126 2018.06.21
- International Application: PCT/EP2019/066414 2019.06.20
- International Announcement: WO2019/243550A 2019.12.26
- Date entered country: 2020-12-09
- Main IPC: C07D409/14
- IPC: C07D409/14 ; C07D333/50 ; C07D333/78 ; C07D409/04 ; C07D409/06 ; C07D409/12 ; C07D413/04 ; C07D413/12 ; C07D417/12 ; C07D487/04 ; C07D495/04 ; C07D495/10 ; C07D498/10
Abstract:
Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.
Public/Granted literature
- US20220332709A1 Thiophene derivatives for the treatment of disorders caused by IgE Public/Granted day:2022-10-20
Information query
